DETECTION OF IMPAIRED FIBRINOLYTIC-ACTIVITY IN CORONARY-ARTERY DISEASE - ELECTROPHORETIC AND IMMUNOBLOTTING ANALYSIS OF TISSUE PLASMINOGEN-ACTIVATOR

被引：2

|

作者：

UNO, M

TSUJI, H

WATANABE, M

TAKABUCHI, H

KOBAYASHI, K

SHIRAI, K

SAWADA, S

TOYODA, T

NAKAGAWA, M

机构：

来源：

JAPANESE CIRCULATION JOURNAL-ENGLISH EDITION | 1989年 / 53卷 / 03期

关键词：

D O I：

10.1253/jcj.53.229

中图分类号：

N09 [自然科学史]; B [哲学、宗教];

学科分类号：

01 ; 0101 ; 010108 ; 060207 ; 060305 ; 0712 ;

摘要：

引用

收藏

页码：229 / 236

页数：8

相关论文

共 50 条

[41] EFFECT OF ESSENTIAL OIL OF GARLIC ON SERUM FIBRINOLYTIC-ACTIVITY IN PATIENTS WITH CORONARY-ARTERY DISEASE
BORDIA, AK
JOSHI, HK
SANADHYA, YK
BHU, N
ATHEROSCLEROSIS, 1977, 28 (02) : 155 - 159
[42] RESISTANCE TO CORONARY THROMBOLYSIS WITH INTRAVENOUS TISSUE PLASMINOGEN-ACTIVATOR - EVIDENCE FOR A FIBRINOLYTIC DEFECT
TOPOL, EJ
KLINE, E
STUMP, D
COLLEN, D
PITT, B
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 9 (02) : A190 - A190
[43] EFFECTS OF HEPARIN AND INTRAVENOUS TISSUE PLASMINOGEN-ACTIVATOR OR STREPTOKINASE IN A CANINE MODEL OF CORONARY-ARTERY THROMBOSIS
MICKELSON, JK
SIMPSON, PJ
LUCCHESI, BR
CLINICAL RESEARCH, 1987, 35 (03): : A305 - A305
[44] BISPECIFIC MONOCLONAL-ANTIBODIES INCREASE THE FIBRIN-SPECIFIC FIBRINOLYTIC-ACTIVITY OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR (TPA) AND UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA)
BOS, R
NIEUWENHUIZEN, W
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1992, 667 : 428 - 430
[45] THE EFFECT OF TOPICALLY APPLIED TISSUE-TYPE PLASMINOGEN-ACTIVATOR ON FIBRINOLYTIC-ACTIVITY AND THROMBUS FORMATION AFTER VASCULAR INJURY
UNDERWOOD, MJ
MORE, RS
DEBONO, DP
THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1278 - 1278
[46] BOVINE CORONARY-ARTERY ENDOTHELIUM - INVITRO CULTURE AND PRODUCTION OF PLASMINOGEN-ACTIVATOR
ZIATS, NP
GOLDSMITH, GH
MEDVEDEFF, ED
ROBERTSON, AL
THROMBOSIS RESEARCH, 1986, 41 (02) : 239 - 250
[47] PLASMINOGEN-ACTIVATOR INHIBITOR ACTIVITY AS A POSSIBLE INDICATOR OF DISEASE-ACTIVITY IN REST ANGINA WITH ANGIOGRAPHICALLY INSIGNIFICANT CORONARY-ARTERY STENOSIS
SAKATA, K
KURATA, C
KOBAYASHI, A
RYDZEWSKI, A
YAMAZAKI, N
THROMBOSIS RESEARCH, 1991, 63 (05) : 491 - 502
[48] TISSUE-TYPE PLASMINOGEN-ACTIVATOR AND TYPE-1 PLASMINOGEN-ACTIVATOR INHIBITOR IN PATIENTS WITH CORONARY-ARTERY DISEASE - RELATIONS TO CLINICAL-VARIABLES AND CARDIOVASCULAR RISK-FACTORS
GEPPERT, A
BECKMANN, R
GRAF, S
HORNYKEWYCZ, S
LANG, I
SCHUSTER, E
BINDER, BR
HUBER, K
FIBRINOLYSIS, 1995, 9 : 109 - 113
[49] EFFECT OF LOCALLY APPLIED TISSUE-TYPE PLASMINOGEN-ACTIVATOR ON VENOUS FIBRINOLYTIC-ACTIVITY - IN-VITRO AND IN-VIVO INVESTIGATIONS
UNDERWOOD, MJ
MORE, RS
GERSHLICK, AH
DEBONO, DP
CARDIOVASCULAR RESEARCH, 1993, 27 (12) : 2270 - 2273
[50] DEXTRANSULFATE (DS) STIMULATED FIBRINOLYTIC-ACTIVITY IN RELATION TO THE ACTIVITY OF TISSUE PLASMINOGEN-ACTIVATOR (T-PA) AND SINGLE AND 2 CHAIN URINARY TYPE PLASMINOGEN-ACTIVATOR [(SC+TC) U-PA]
HIMMELREICH, G
KIERZEK, B
RIESS, H
FIBRINOLYSIS, 1990, 4 : 150 - 151

← 1 2 3 4 5 →